‹ ›
MYP_151724
← PREVIOUS NEXT → BACK
Basic Information
Haloganan
Antimicrobial
Antimicrobial ▸ Antibacterial
Standard
19 amino acids
C96H156N30O23S
Standard
Sequence
KWQNALLHHGLNCAKGVLK
Physicochemical Analysis
2130.52 Da
9.79
2.92
2.60
0.1538
-0.25
0.50
0.05
-6.44
107.89
0.0526
5500.00
5500.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
867.60
-6.74
30.0
29.0
72.0
150.0
4.0
21.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0037310 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Halocidin
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
APD analysis reveals that this sequence is 89.47% similar to HG1 L: 21%, K: 16%, A=G=N=H: 11%. Warning: chain B sequence is the same as chain A. Chemical modification: there is an intermolecular S-S bond between the two chains
Bio-Activity Profile
Antimicrobial
S. enterica KCTC 2930
4 μg/mL
MIC
PaperHaloganan: a novel antimicrobial peptide for treatmentof wound infections.
RECORD: Rec_0101015 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Halocidin
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
APD analysis reveals that this sequence is 89.47% similar to HG1 L: 21%, K: 16%, A=G=N=H: 11%. Warning: chain B sequence is the same as chain A. Chemical modification: there is an intermolecular S-S bond between the two chains
Bio-Activity Profile
Antimicrobial
K. oxytoca KCTC 1686
4 μg/mL
MIC
PaperHaloganan: a novel antimicrobial peptide for treatmentof wound infections.
RECORD: Rec_0136992 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Halocidin
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
APD analysis reveals that this sequence is 89.47% similar to HG1 L: 21%, K: 16%, A=G=N=H: 11%. Warning: chain B sequence is the same as chain A. Chemical modification: there is an intermolecular S-S bond between the two chains
Bio-Activity Profile
Antimicrobial
Staphylococcus aureus MRSA
4 μg/mL
MIC
PaperHaloganan: a novel antimicrobial peptide for treatmentof wound infections.
RECORD: Rec_0157285 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Amidation
Bio-Activity Profile
Antimicrobial Antibacterial
Micrococcus luteus KCTC9341
PMID25445605 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/25445605/
RECORD: Rec_0173292 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Halocidin
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
APD analysis reveals that this sequence is 89.47% similar to HG1 L: 21%, K: 16%, A=G=N=H: 11%. Warning: chain B sequence is the same as chain A. Chemical modification: there is an intermolecular S-S bond between the two chains
Bio-Activity Profile
Antimicrobial
vancomycin-resistant E. faecium strain CCARM 5028 anti-VRE
4 μg/mL
MIC
PaperHaloganan: a novel antimicrobial peptide for treatmentof wound infections.
1 2 3 4 NEXT LAST
Showing 5 records on this page · Page 1 of 4